Pfizer Delays Attempt to Vanquish Warner-Lambert's Board

Publish date:


(PFE) - Get Report

said it will not begin an effort to oust



board of directors until a court rules on whether its unsolicited $72.6 billion takeover offer violated a deal under which the two companies co-market the drug Lipitor.

After-Hours Trading

Biotechnology stocks dominated trading on Island ECN in after-hours trading on Thursday.

Biomune Systems


was the most active, followed by




Genome Therapeutics

(GENE) - Get Report


Island ECN, owned by Datek Online, offers trading, mainly in Nasdaq-listed stocks, from 8 a.m. to 8 p.m. EST.


MarketXT, formerly Eclipse Trading, offers after-hours trading to retail clients of Morgan Stanley Dean Witter's (MWD) Morgan Stanley Dean Witter Online and Mellon Bank's (MEL) Dreyfus Brokerage Services. Clients can trade 200 of the most actively traded New York Stock Exchange and Nasdaq Stock Market issues, 4:30 p.m. to 8 p.m. EST Monday through Thursday.


explains how the rules change when the sun goes down in Investing Basics: Night Owl, a section devoted to after-hours trading.


Eric Gillin

In other post-close news (

Earnings estimates from First Call/Thomson Financial; earnings reported on a diluted basis unless otherwise specified.


Earnings/revenue reports and previews

Western Gas


said it sees a fourth-quarter loss of 13 cents a share, well below the five-analyst estimate of a profit of 8 cents a share.

Mergers, acquisitions and joint ventures

First Security


said it was delaying a Dec. 28 shareholder meeting on its pending merger with

Zions Bancorp

(ZION) - Get Report

because Zions said it had to restate its financial statements to reclassify some of its acquisitions from 1997 and 1998.

Offerings and stock actions

Neurocrine Biosciences

(NBIX) - Get Report

said it entered into a definitive agreements to sell 2.3 million newly issued shares to five institutional investors for $42 million. The company said the purchase price was $18 a share.

As originally published, this story contained an error. Please see

Corrections and Clarifications.